Home
/
enVVeno Medical Corp
/
Financials
/
Quarterly
enVVeno Medical Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that enVVeno Medical Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2019
$31.2K
Nov 17, 2020
Q2
2020
Jun 30, 2019
$31.2K
Aug 14, 2020
Q1
2020
Mar 31, 2019
$31.2K
Jun 8, 2020
Q3
2019
Sep 30, 2018
$41.7K
Oct 31, 2019
Q2
2019
Jun 30, 2018
$83.4K
Aug 5, 2019
Q1
2019
Mar 31, 2018
$31.1K
May 9, 2019
Q3
2018
Sep 30, 2017
$27.9K
Nov 7, 2018
Q2
2018
Jun 30, 2017
$38.8K
Aug 10, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.54M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($6.69M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($4.50M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($5.64M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($4.96M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($4.99M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($5.00M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($6.47M)
Jul 31, 2024
Q1
2024
Mar 31, 2023
($6.39M)
May 8, 2024
Q3
2023
Sep 30, 2022
($6.10M)
Oct 26, 2023
Q3
2022
Jun 30, 2022
($7.06M)
Oct 27, 2022
Q2
2023
Jun 30, 2022
($7.06M)
Jul 31, 2023
Q1
2023
Mar 31, 2022
($5.33M)
Apr 28, 2023
Q3
2022
Mar 31, 2022
($5.33M)
Oct 27, 2022
Q2
2022
Mar 31, 2022
($5.33M)
Aug 3, 2022
Q3
2022
Sep 30, 2021
($2.39M)
Oct 27, 2022
Q3
2022
Jun 30, 2021
($2.38M)
Oct 27, 2022
Q2
2022
Jun 30, 2021
($2.38M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($2.77M)
Apr 29, 2022
Q2
2022
Mar 31, 2021
($2.77M)
Aug 3, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.88M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($7.05M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($4.95M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($6.17M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($5.45M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($5.50M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($5.35M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($6.81M)
Jul 31, 2024
Q1
2024
Mar 31, 2023
($6.80M)
May 8, 2024
Q3
2023
Sep 30, 2022
($6.15M)
Oct 26, 2023
Q2
2023
Jun 30, 2022
($6.99M)
Jul 31, 2023
Q1
2023
Mar 31, 2022
($5.34M)
Apr 28, 2023
Q3
2022
Sep 30, 2021
($2.71M)
Oct 27, 2022
Q2
2022
Jun 30, 2021
($2.39M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($2.81M)
Apr 29, 2022
Q3
2021
Sep 30, 2020
($1.92M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.55M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($1.51M)
May 12, 2021
Q3
2020
Sep 30, 2019
($1.83M)
Nov 17, 2020
Q2
2020
Jun 30, 2019
($1.96M)
Aug 14, 2020